Kraemer Matthias, Kara David
Abteilung Allgemeine und Viszeralchirurgie, Koloproktologie, St. Barbara-Klinik, Am Heessener Wald 1, 59073, Hamm, Germany.
Int J Colorectal Dis. 2016 Jan;31(1):19-22. doi: 10.1007/s00384-015-2395-3. Epub 2015 Sep 30.
Entero-vesical or entero-vaginal fistulae (EVF) are an uncommon septic complication mainly of diverticular disease. The fistulae are usually situated within extensive and dense inflammatory masses occluding the entrance of the pelvis. There are still some controversies regarding laparoscopic feasibility and treatment modalities of this disorder.
A retrospective chart review of all patients with EVF operated at our department since 2008. Patients were identified by use of the computerized hospital information system.
In nineteen patients (ten males), median age 68 years, 13 patients had entero-vesical fistulae, and 6 patients had entero-vaginal fistulae. The fistulae were caused by complicated diverticular disease in 16 patients (84 %), Crohn's disease (two patients), and ulcerative colitis (one patient). All cases were attempted laparoscopically. Operative treatment involved separation of the inflammatory mass and resection of the affected colorectal segment. There were three conversions (16 %), all three requiring bladder repair considered too extensive for laparoscopic means. In two further patients small bladder defects were sutured laparoscopically, the remaining patients required no bladder repair. The inferior mesentric artery (IMA) was preserved in all cases. Median operative time was 180 min. Two patients received a protective ileostomy: one converted patient and one cachectic patient with Crohn's disease under immune-modulating therapy. Both ileostomies were closed. Altogether, there were five complications in five patients (26 %), four of them were minor (Clavien grade I and II). The cachectic patient with Crohn's disease suffered a major (grade IIIb) complication (stoma prolapse, treated by early closure of the ileostomy). There was no anastomotic leakage and no mortality. Median hospital stay was 12 days.
The laparoscopic approach is a safe option for the treatment of EVF of benign inflammatory origin. In most cases it offers all the advantages pertaining to minimally invasive surgery. For a definite and causal approach, the disorder belongs primarily within the therapeutic domain of the visceral surgeon. Following the separation of the inflammatory colon, most of the bladder lesions caused by EVF will heal without further surgical measures.
肠膀胱或肠阴道瘘(EVF)是一种主要由憩室病引起的罕见感染性并发症。瘘管通常位于阻塞盆腔入口的广泛致密炎性肿块内。关于这种疾病的腹腔镜可行性和治疗方式仍存在一些争议。
对2008年以来在我科接受手术的所有EVF患者进行回顾性病历审查。通过计算机化医院信息系统识别患者。
19例患者(10例男性),中位年龄68岁,13例为肠膀胱瘘,6例为肠阴道瘘。瘘管由复杂性憩室病引起的有16例(84%),克罗恩病(2例),溃疡性结肠炎(1例)。所有病例均尝试腹腔镜手术。手术治疗包括分离炎性肿块和切除受累的结直肠段。有3例中转开腹(16%),所有3例均因膀胱修复范围过大,认为无法通过腹腔镜完成。另有2例患者的小膀胱缺损通过腹腔镜缝合,其余患者无需膀胱修复。所有病例均保留肠系膜下动脉(IMA)。中位手术时间为180分钟。2例患者接受了预防性回肠造口术:1例中转开腹患者和1例接受免疫调节治疗的克罗恩病恶病质患者。两个回肠造口均已关闭。共有5例患者出现5种并发症(26%),其中4例为轻微并发症(Clavien I级和II级)。患有克罗恩病的恶病质患者出现了严重(IIIb级)并发症(造口脱垂,通过早期关闭回肠造口治疗)。无吻合口漏,无死亡病例。中位住院时间为12天。
腹腔镜手术是治疗良性炎性起源的EVF的安全选择。在大多数情况下,它具有微创手术的所有优点。对于明确的病因治疗方法,该疾病主要属于内脏外科医生的治疗范畴。在分离炎性结肠后,大多数由EVF引起的膀胱病变无需进一步手术措施即可愈合。